Akebia Therapeutics AKBA
NASDAQ AKBA
$0.57 -0.02 (-2.94%)
As of: Oct 22, 2026 · 10:57 AM EDT

Akebia Therapeutics (AKBA) Other financing activities (2013 - 2025)

Updated

Akebia Therapeutics (AKBA) posted Other financing activities of $63,000 for FY2025, down 95.0% from $1.27 million in FY2024.

Analysis

Akebia Therapeutics (AKBA) Other financing activities (2013 - 2025) Analysis & Trends

Since FY2021, Akebia Therapeutics has reported Other financing activities for 4 years.

  • Annual Other financing activities shows a four-year compound annual growth rate of -80.6% (FY2021 to FY2025).
  • Business Quant data shows AKBA's Other financing activities at $1.27 million in FY2024, $40 million in FY2022 (-10.7%) and $44.78 million in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,167.56 Bn 1,136.14 Bn 19.71 Bn
2 Johnson & Johnson 635.76 Bn 554.29 Bn 17.26 Bn
3 AbbVie 503.27 Bn 476.38 Bn 12.70 Bn
4 Merck 377.51 Bn 331.89 Bn 12.21 Bn
5 Novartis Ag 304.07 Bn 268.06 Bn 11.24 Bn
6 Astrazeneca 267.53 Bn 241.22 Bn 12.86 Bn
7 Amgen 242.06 Bn 197.46 Bn 7.24 Bn
8 Gilead Sciences 194.26 Bn 168.46 Bn 6.22 Bn
9 Pfizer 172.62 Bn 119.27 Bn 10.94 Bn
10 Akebia Therapeutics 153.67 Mn -515.81 Mn 38.70 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 -63,000.00
Sep 30, 2024 -522,000.00
Mar 31, 2024 -750,000.00
Mar 31, 2022 40.00 Mn
Mar 31, 2021 44.78 Mn
Sep 30, 2014 10.60 Mn
Jun 30, 2014 -1.16 Mn
Mar 31, 2014 -9.20 Mn
Jun 30, 2013 -1.14 Mn
Mar 31, 2013 -17,348.00
API Access

Akebia Therapeutics Other financing activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-financing-activities&ticker=AKBA&period=max&api_key=YOUR_API_KEY